Skip to content

Comparison of pain rate in buccal infiltration with Mepivacaine and Articaine with epinephrine injection in upper premolars region

Comparative Study of pain rate in buccal infiltration with Mepivacaine and Articaine with epinephrine injection in upper premolars region in patients that refer to the surgical department of dental school

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016062914333N53
Enrollment
30
Registered
2016-08-10
Start date
2016-08-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

?Acute pain. Pain, not elsewhere classified

Interventions

Intervention 1: In the experimental group, the intervention will be carried out on the upper right jaw and Mepivacaine will injected. Intervention 2: In the experimental group,second intervention wil
Treatment - Drugs
In the experimental group, the intervention will be carried out on the upper right jaw and Mepivacaine will injected.
In the experimental group,second intervention will be carried out on the upper right jaw without time interval and Articaine with epinephrine will injected.Then during the injection and in 5, 15, 3

Sponsors

Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences , Kermanshah Univers
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: lack of sensitivity to inject; lack of sensitivity to Mepivacaine and Articaine; No pregnancy for women Exclusion criteria: Unbearable pain

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The intensity of pain. Timepoint: In 5, 15, 30 and 45 seconds during injection. Method of measurement: Based on the visual analogue scale (VAS).

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026